PATENT CLAIM ANALYSIS

Application Number: 16224573
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-07
Patent Classification: ["514", "171000"]

Abstract:
The embodiments described herein include methods and formulations for treating viruses and diseases that are exacerbated by inflammatory responses in the body. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.

Claim (Index 17):
A combination of levocetirizine and montelukast for use in the treatment of a neurodegenerative disease.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 98.0
- Lexical Diversity: 1.57778
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15450840', '15895918', '13704589', '14974930', '15348253']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7787993904683292
- 35 USC 102 Novelty (BERT): 0.600216290405407
- Combined Prediction Score: 0.7609410804620371
- Mean Citation Score: 370.432736
- Max Citation Score: 563.5654
- Similarity Product: 488.28757585673327

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test